9
Formation and Characterization of Mefenamic acid-Nicotinamide Cocrystal During Co-milling Based on X-ray Powder Diffraction Analysis By DWI UTAMI WORD COUNT 4174 T IME SUBMIT T ED 01-NOV-2018 06:38AM PAPER ID 41635863

During Co-milling Based on X-ray Powder Mefenamic acid

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: During Co-milling Based on X-ray Powder Mefenamic acid

Formation and Characterization ofMefenamic acid-Nicotinamide Cocrystal

During Co-milling Based on X-ray PowderDiffraction Analysis

By DWI UTAMI

WORD COUNT 4174 TIME SUBMITTED 01-NOV-2018 06:38AM

PAPER ID 41635863

Page 2: During Co-milling Based on X-ray Powder Mefenamic acid
Page 3: During Co-milling Based on X-ray Powder Mefenamic acid
Page 4: During Co-milling Based on X-ray Powder Mefenamic acid
Page 5: During Co-milling Based on X-ray Powder Mefenamic acid
Page 6: During Co-milling Based on X-ray Powder Mefenamic acid
Page 7: During Co-milling Based on X-ray Powder Mefenamic acid
Page 8: During Co-milling Based on X-ray Powder Mefenamic acid
Page 9: During Co-milling Based on X-ray Powder Mefenamic acid

98%SIMILARITY INDEX

1

2

EXCLUDE QUOTES ON

EXCLUDE BIBLIOGRAPHY ON

EXCLUDE MATCHES OFF

Formation and Characterization of Mefenamic acid-Nicotinamide Cocrystal During Co-milling Based on X-rayPowder Diffraction AnalysisORIGINALITY REPORT

PRIMARY SOURCES

Dwi Utami, Ilma Nugrahani, Slamet Ibrahim."Formation and Characterization of Mefenamicacid-Nicotinamide Cocrystal during Co-milling Based on X-rayPowder Diffraction Analysis", Journal of Applied PharmaceuticalScience, 2016Crossref

Rai, A.K.. "Spectroscopic studies of someantidiabetic drugs", Spectrochimica Acta Part A:Molecular and Biomolecular Spectroscopy, 200306Crossref

3611 words — 97%

7 words — < 1%